JP2022141640A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2022141640A5 JP2022141640A5 JP2022096962A JP2022096962A JP2022141640A5 JP 2022141640 A5 JP2022141640 A5 JP 2022141640A5 JP 2022096962 A JP2022096962 A JP 2022096962A JP 2022096962 A JP2022096962 A JP 2022096962A JP 2022141640 A5 JP2022141640 A5 JP 2022141640A5
- Authority
- JP
- Japan
- Prior art keywords
- treatment
- peptide
- seq
- digested
- protease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 claims 29
- 108090000765 processed proteins & peptides Proteins 0.000 claims 26
- 108010000487 High-Molecular-Weight Kininogen Proteins 0.000 claims 11
- 102100035792 Kininogen-1 Human genes 0.000 claims 11
- 102000035195 Peptidases Human genes 0.000 claims 7
- 108091005804 Peptidases Proteins 0.000 claims 7
- 239000004365 Protease Substances 0.000 claims 7
- 239000012472 biological sample Substances 0.000 claims 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 5
- 230000001404 mediated effect Effects 0.000 claims 5
- 102000004196 processed proteins & peptides Human genes 0.000 claims 5
- 108010051815 Glutamyl endopeptidase Proteins 0.000 claims 3
- 239000000137 peptide hydrolase inhibitor Substances 0.000 claims 3
- LKDMKWNDBAVNQZ-UHFFFAOYSA-N 4-[[1-[[1-[2-[[1-(4-nitroanilino)-1-oxo-3-phenylpropan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-oxobutanoic acid Chemical compound OC(=O)CCC(=O)NC(C)C(=O)NC(C)C(=O)N1CCCC1C(=O)NC(C(=O)NC=1C=CC(=CC=1)[N+]([O-])=O)CC1=CC=CC=C1 LKDMKWNDBAVNQZ-UHFFFAOYSA-N 0.000 claims 2
- 108090000617 Cathepsin G Proteins 0.000 claims 2
- 102000004173 Cathepsin G Human genes 0.000 claims 2
- 206010019860 Hereditary angioedema Diseases 0.000 claims 2
- 108010058188 Low-Molecular-Weight Kininogen Proteins 0.000 claims 2
- 102000003827 Plasma Kallikrein Human genes 0.000 claims 2
- 108090000113 Plasma Kallikrein Proteins 0.000 claims 2
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 claims 2
- 239000003146 anticoagulant agent Substances 0.000 claims 2
- 229940127219 anticoagulant drug Drugs 0.000 claims 2
- 239000008280 blood Substances 0.000 claims 2
- 210000004369 blood Anatomy 0.000 claims 2
- 239000003638 chemical reducing agent Substances 0.000 claims 2
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 claims 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 1
- 229940123765 Bradykinin B2 receptor antagonist Drugs 0.000 claims 1
- 108090000317 Chymotrypsin Proteins 0.000 claims 1
- 102000055157 Complement C1 Inhibitor Human genes 0.000 claims 1
- 108700040183 Complement C1 Inhibitor Proteins 0.000 claims 1
- 102000001399 Kallikrein Human genes 0.000 claims 1
- 108060005987 Kallikrein Proteins 0.000 claims 1
- 108010030544 Peptidyl-Lys metalloendopeptidase Proteins 0.000 claims 1
- 241001274197 Scatophagus argus Species 0.000 claims 1
- 239000011230 binding agent Substances 0.000 claims 1
- 239000003359 bradykinin B2 receptor antagonist Substances 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 229960002376 chymotrypsin Drugs 0.000 claims 1
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 claims 1
- 238000006073 displacement reaction Methods 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 108010003914 endoproteinase Asp-N Proteins 0.000 claims 1
- 125000000291 glutamic acid group Chemical group N[C@@H](CCC(O)=O)C(=O)* 0.000 claims 1
- 239000003112 inhibitor Substances 0.000 claims 1
- 239000012669 liquid formulation Substances 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 239000000523 sample Substances 0.000 claims 1
- 229940124597 therapeutic agent Drugs 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024005910A JP7758766B2 (ja) | 2015-12-15 | 2024-01-18 | 完全長の高分子量キニノーゲン（ｈｍｗｋ）と切断されたｈｍｗｋとを区別するためのペプチド定量アッセイ |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562267734P | 2015-12-15 | 2015-12-15 | |
| US62/267,734 | 2015-12-15 | ||
| JP2018531159A JP7092669B2 (ja) | 2015-12-15 | 2016-12-15 | 完全長の高分子量キニノーゲン（ｈｍｗｋ）と切断されたｈｍｗｋとを区別するためのペプチド定量アッセイ |
| PCT/US2016/066936 WO2017106504A1 (en) | 2015-12-15 | 2016-12-15 | Peptide quantitation assay for differentiating full-length high molecular weight kininogen (hmwk) and cleaved hmwk |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018531159A Division JP7092669B2 (ja) | 2015-12-15 | 2016-12-15 | 完全長の高分子量キニノーゲン（ｈｍｗｋ）と切断されたｈｍｗｋとを区別するためのペプチド定量アッセイ |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024005910A Division JP7758766B2 (ja) | 2015-12-15 | 2024-01-18 | 完全長の高分子量キニノーゲン（ｈｍｗｋ）と切断されたｈｍｗｋとを区別するためのペプチド定量アッセイ |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022141640A JP2022141640A (ja) | 2022-09-29 |
| JP2022141640A5 true JP2022141640A5 (enExample) | 2023-06-16 |
| JP7425117B2 JP7425117B2 (ja) | 2024-01-30 |
Family
ID=57794352
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018531159A Active JP7092669B2 (ja) | 2015-12-15 | 2016-12-15 | 完全長の高分子量キニノーゲン（ｈｍｗｋ）と切断されたｈｍｗｋとを区別するためのペプチド定量アッセイ |
| JP2022096962A Active JP7425117B2 (ja) | 2015-12-15 | 2022-06-16 | 完全長の高分子量キニノーゲン（ｈｍｗｋ）と切断されたｈｍｗｋとを区別するためのペプチド定量アッセイ |
| JP2024005910A Active JP7758766B2 (ja) | 2015-12-15 | 2024-01-18 | 完全長の高分子量キニノーゲン（ｈｍｗｋ）と切断されたｈｍｗｋとを区別するためのペプチド定量アッセイ |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018531159A Active JP7092669B2 (ja) | 2015-12-15 | 2016-12-15 | 完全長の高分子量キニノーゲン（ｈｍｗｋ）と切断されたｈｍｗｋとを区別するためのペプチド定量アッセイ |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024005910A Active JP7758766B2 (ja) | 2015-12-15 | 2024-01-18 | 完全長の高分子量キニノーゲン（ｈｍｗｋ）と切断されたｈｍｗｋとを区別するためのペプチド定量アッセイ |
Country Status (13)
| Country | Link |
|---|---|
| US (3) | US11668718B2 (enExample) |
| EP (2) | EP3390439B1 (enExample) |
| JP (3) | JP7092669B2 (enExample) |
| KR (2) | KR102874711B1 (enExample) |
| CN (1) | CN108602877A (enExample) |
| AU (3) | AU2016372159B2 (enExample) |
| CA (1) | CA3008621A1 (enExample) |
| CO (1) | CO2018007216A2 (enExample) |
| EA (1) | EA201891414A1 (enExample) |
| IL (4) | IL297850B2 (enExample) |
| MX (2) | MX2018007493A (enExample) |
| NZ (1) | NZ743482A (enExample) |
| WO (1) | WO2017106504A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20250066486A (ko) | 2013-10-21 | 2025-05-13 | 다케다 파머수티컬 컴패니 리미티드 | 혈장 칼리크레인 시스템 바이오마커를 결정하기 위한 검정법 |
| KR102665705B1 (ko) | 2013-10-21 | 2024-05-14 | 다케다 파머수티컬 컴패니 리미티드 | 자가면역 질환의 진단 및 치료 |
| EP3365685B1 (en) | 2015-10-19 | 2020-11-25 | Dyax Corp. | Immunoassay to detect cleaved high molecular weight kininogen |
| AU2016372159B2 (en) | 2015-12-15 | 2022-03-24 | Takeda Pharmaceutical Company Limited | Peptide quantitation assay for differentiating full-length high molecular weight kininogen (HMWK) and cleaved HMWK |
| EP3637106B1 (en) * | 2017-06-08 | 2023-03-22 | University of Miyazaki | Lung cancer detection method |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5047323A (en) * | 1986-01-22 | 1991-09-10 | Temple University Of The Commonwealth System Of Higher Education | Method for detecting human kininogen using monoclonal antibodies thereto |
| JP2603487B2 (ja) | 1987-11-26 | 1997-04-23 | 大日本製薬株式会社 | ガンに罹患している疑いのあるヒトをスクリーニングする方法 |
| JPH08208692A (ja) | 1994-09-28 | 1996-08-13 | Sumitomo Pharmaceut Co Ltd | 新規な細胞接着抑制ペプチド誘導体 |
| JP3073439B2 (ja) | 1996-02-08 | 2000-08-07 | 雪印乳業株式会社 | 骨形成促進及び骨吸収防止剤 |
| DE69931140T2 (de) | 1998-11-10 | 2007-02-01 | Temple University Of The Commonwealth System Of Higher Education | Hemmung der angiogenese durch peptidanaloge der kininogen domäne 5mit hohem molekulargewicht |
| US20060154319A1 (en) | 1999-04-29 | 2006-07-13 | Flodgaard Hans J | Inhibition of bradykinin release |
| WO2001034195A1 (en) | 1999-11-12 | 2001-05-17 | Temple University Of The Commonwealth System Of Higher Education | Inhibition of angiogenesis by antibodies against high molecular weight kininogen domain 5 |
| WO2003077872A2 (en) | 2002-03-15 | 2003-09-25 | Attenuon, Llc | Cell surface tropomyosin as a target of angiogenesis inhibition |
| CN1858243A (zh) | 2005-04-30 | 2006-11-08 | 安徽省生物医学研究所 | 一种预测血管紧张素ii受体拮抗剂类降压药药物作用的方法及其应用 |
| WO2009051259A1 (ja) | 2007-10-18 | 2009-04-23 | Miyazaki Prefectural Industrial Support Foundation | 肝疾患診断用バイオマーカー |
| KR20110057086A (ko) | 2008-07-07 | 2011-05-31 | 니폰 조키 세야쿠 가부시키가이샤 | 섬유근 통증의 검사법 |
| GB0821721D0 (en) | 2008-11-27 | 2008-12-31 | Hansa Medical Ab | Antimicrobial therapy |
| EP2770327B1 (en) | 2009-03-30 | 2017-06-14 | Nordic Bioscience A/S | Fibrosis biomarker assay |
| JP5714285B2 (ja) | 2010-09-29 | 2015-05-07 | 株式会社プロトセラ | 妊娠高血圧症候群マーカーおよびそれを用いた診断 |
| CN102558329A (zh) | 2010-12-10 | 2012-07-11 | 中国人民解放军军事医学科学院生物医学分析中心 | 一组特异性多肽及其在制备肺癌早期诊断试剂中的用途 |
| HRP20180928T1 (hr) | 2012-03-28 | 2018-07-27 | Sanofi | Protutijela za ligande bradikinin b1 receptora |
| JP6444315B2 (ja) | 2013-01-20 | 2018-12-26 | ダイアックス コーポレーション | ブラジキニン媒介障害の評価および治療 |
| JP2016188761A (ja) | 2013-08-23 | 2016-11-04 | 国立研究開発法人国立国際医療研究センター | 糖尿病腎症の発症または発症リスクの検出方法及びキット |
| KR20250066486A (ko) * | 2013-10-21 | 2025-05-13 | 다케다 파머수티컬 컴패니 리미티드 | 혈장 칼리크레인 시스템 바이오마커를 결정하기 위한 검정법 |
| US10281473B2 (en) * | 2014-02-04 | 2019-05-07 | University Of Virginia Patent Foundation | Compositions and methods for analysis of protein sequences and post-translational modifications |
| CN104155457B (zh) | 2014-08-22 | 2016-11-16 | 北京蛋白质组研究中心 | 一种结直肠癌相关“多肽-蛋白组合式标志物”检测试剂盒 |
| CN104345154B (zh) | 2014-08-22 | 2016-10-26 | 北京蛋白质组研究中心 | 一种检测多肿瘤相关“多肽-蛋白组合式标志物”的双抗体夹心试剂盒 |
| WO2016081413A1 (en) * | 2014-11-17 | 2016-05-26 | The Rockefeller University | Compositions and methods for use in diagnosis of alzheimer's disease |
| AU2016372159B2 (en) | 2015-12-15 | 2022-03-24 | Takeda Pharmaceutical Company Limited | Peptide quantitation assay for differentiating full-length high molecular weight kininogen (HMWK) and cleaved HMWK |
-
2016
- 2016-12-15 AU AU2016372159A patent/AU2016372159B2/en active Active
- 2016-12-15 WO PCT/US2016/066936 patent/WO2017106504A1/en not_active Ceased
- 2016-12-15 CO CONC2018/0007216A patent/CO2018007216A2/es unknown
- 2016-12-15 US US16/062,734 patent/US11668718B2/en active Active
- 2016-12-15 NZ NZ743482A patent/NZ743482A/en unknown
- 2016-12-15 KR KR1020247036874A patent/KR102874711B1/ko active Active
- 2016-12-15 EA EA201891414A patent/EA201891414A1/ru unknown
- 2016-12-15 IL IL297850A patent/IL297850B2/en unknown
- 2016-12-15 EP EP16825947.1A patent/EP3390439B1/en active Active
- 2016-12-15 CA CA3008621A patent/CA3008621A1/en active Pending
- 2016-12-15 JP JP2018531159A patent/JP7092669B2/ja active Active
- 2016-12-15 IL IL312919A patent/IL312919B1/en unknown
- 2016-12-15 MX MX2018007493A patent/MX2018007493A/es unknown
- 2016-12-15 EP EP25162494.6A patent/EP4597115A3/en active Pending
- 2016-12-15 IL IL322971A patent/IL322971A/en unknown
- 2016-12-15 KR KR1020187020049A patent/KR102728491B1/ko active Active
- 2016-12-15 CN CN201680079865.9A patent/CN108602877A/zh active Pending
-
2018
- 2018-06-13 IL IL259995A patent/IL259995B2/en unknown
- 2018-06-15 MX MX2023000773A patent/MX2023000773A/es unknown
-
2022
- 2022-06-10 AU AU2022204058A patent/AU2022204058B2/en active Active
- 2022-06-16 JP JP2022096962A patent/JP7425117B2/ja active Active
-
2023
- 2023-04-28 US US18/308,813 patent/US12135329B2/en active Active
-
2024
- 2024-01-18 JP JP2024005910A patent/JP7758766B2/ja active Active
- 2024-09-24 US US18/894,192 patent/US20250172567A1/en active Pending
-
2025
- 2025-01-22 AU AU2025200412A patent/AU2025200412A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022141640A5 (enExample) | ||
| EP3578664B1 (en) | Collagen iv neo-epitope fibrosis assay | |
| JP2024150637A5 (enExample) | ||
| JP2024026847A5 (enExample) | ||
| AU2008203968A1 (en) | Peptide markers for diagnosis of angiogenesis | |
| US12135329B2 (en) | Peptide quantitation assay for differentiating full-length high molecular weight kininogen (HMWK) and cleaved HMWK | |
| CN111742222A (zh) | 诊断遗传性血管性水肿的方法 | |
| US8114613B2 (en) | Oxidized APOA1 determination by mass spectrometry | |
| AU2012347263A1 (en) | LTBP2 as a biomarker for lung injury | |
| JP2019505185A5 (enExample) | ||
| Dickeson et al. | A mechanism for hereditary angioedema caused by a methionine-379–to–lysine substitution in kininogens | |
| EP3260859B1 (en) | Inuslin receptor substrate 1 (irs1) protein srm/mrm assay | |
| Menzel et al. | High-throughput biomarker discovery and identification by mass spectrometry | |
| Graf et al. | Increased secretion of the pancreatic secretory trypsin inhibitor (PSTI-I, monitor peptide) during development of chronic pancreatitis in the WBN/Kob rat | |
| NZ783522A (en) | Peptide quantitation assay for differentiating full-length high molecular weight kininogen (HMWK) and cleaved HMWK | |
| NZ783522B2 (en) | Peptide quantitation assay for differentiating full-length high molecular weight kininogen (HMWK) and cleaved HMWK | |
| KR102071122B1 (ko) | 섬유아세포 증식 인자 수용체 2(fgfr2) 단백질에 대한 srm/mrm 분석법 | |
| KR102071121B1 (ko) | 메소텔린(msln) 단백질에 대한 srm/mrm 분석법 | |
| JP2005525535A (ja) | インスリン耐性を示すマクログロブリンバイオポリマーマーカー | |
| EP3749957B1 (en) | Elastin assay | |
| JP2025188193A (ja) | 完全長の高分子量キニノーゲン（ｈｍｗｋ）と切断されたｈｍｗｋとを区別するためのペプチド定量アッセイ | |
| JP2005510726A (ja) | アルツハイマー病を予測する糖タンパク質およびアポリポタンパク質バイオポリマーマーカー | |
| JP2005523425A (ja) | アルツハイマー病を予測するアポリポタンパク質バイオポリマーマーカー | |
| JP2005522414A (ja) | Ｉｉ型糖尿病を予測するアポリポタンパク質バイオポリマーマーカー | |
| Stone | Proteomics in COPD |